T3 Time to Target
for Fixing IV Infliximab Dosing
Time To Target (T3) is a new web-based, Individualized Patient Nomogram/Algorithm specifically developed to easily determine precision dosing based on real patient’s clinical characteristics and a measured trough concentration. Every patient is different, therefore, every patient may need individualized dosing. Physicians can improve treatment outcomes for their inflammatory-disease patients with precision dosing from T3. View large image of patented algorithm.
What Makes T3 Unique
The biological half-life value of the drug is defined as the time it takes for the concentration of the drug in the plasma or the total amount in the body to be reduced by 50%. Identifying the biological half-life value is useful for determining elimination rate as well as steady-state concentrations for the drug.
Baysient’s new app, T3 is an algorithm that will determine the individual half-life of a drug for each patient. By having this information, an accurate indication of the length of time until the drug concentrations fall below the target concentration can be determined. You can learn more about how T3 fixes infliximab dosing in our blog.
Every clinician should be utilizing this algorithm when prescribing patients infliximab because it will help determine doses and intervals that will allow the drug to be present long enough and at a high enough exposure to treat their condition. In some cases, some medical conditions can either shorten or prolong the half-life of a drug, which is why it is important for clinicians to consider half-life when prescribing drugs to avoid prescribing subtherapeutic doses.
Get started with this simple and easy-to-use app for only:
$25 per Month / Unlimited Patients / Cancel Anytime.